中文名称：羟可待酮
  • Oxycodone
  • Percocet; (-)-14-Hydroxydihydrocodeinone; 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one; 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one; 4-27-00-03681 (Beilstein Handbook Reference); BRN 0043446; Codeinone, 7,8-dihydro-14-hydroxy-; Codeinone, dihydro-14-hydroxy-; Codeinone, dihydrohydroxy-; Dihydro-14-hydroxycodeinone; Dihydrohydroxycodeinone; Dihydrone; Dihydroxycodeinone; Diphydrone; Endine (Australia); Endone; Eubine; Eubine [France]; Eucodalum; HSDB 3142; Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-; Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-; NSC 19043; Ossicodone; Ossicodone [DCIT]; Oxanest; Oxicodona; Oxicodona [INN-Spanish]; Oxicon; OxyIR; Oxycodeinone; Oxycodon; Oxycodone Concentrate; Oxycodonum; Oxycodonum [INN-Latin]; Oxyfast; Pancodone retard (United Kingdom); Percobarb; Percodan; Roxicet; Roxicodone; Supendol; Supendol [Canada]; Tylox; UNII-CD35PMG570; Morphinan-6-one, 4,5-alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-; DEA No. 9143
  • 76-42-6
  • 200-960-2
  • C18H21NO4
  • 315.3637
  • InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3
  • 羟可待酮 76-42-6